Silver Nanoparticle Treatment for Carious Lesions, 3-5 Weeks
Summary
The USPTO published patent application US20260096959A1 filed by R.M CREIGHTON DENTAL PTY LTD for a method of treating carious lesions using silver nanoparticles. The treatment involves applying a first dental solution containing a silver salt followed by a second dental solution containing a reducing agent within less than 10 minutes. The lesion consolidates over 3-5 weeks to form a matte black crust containing nanoparticles. Invented by Graham G. Craig.
What changed
The USPTO published patent application US20260096959A1 disclosing a method for treating carious lesions using silver nanoparticles. The invention involves applying a first dental solution comprising a silver salt to the lesion, followed by a second dental solution comprising a reducing agent within 10 minutes. Over 3-5 weeks, the treated lesion consolidates into a matte black crust containing nanoparticles.
This patent application publication provides public notice of the claimed dental treatment method and its technical specifications. For dental product manufacturers, pharmaceutical companies, and healthcare providers, the publication serves as prior art and may inform research and development activities in dental treatment technologies.
What to do next
- Monitor for updates
Archived snapshot
Apr 13, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Method for Producing Silver Nanoparticles in an Active Carious Lesion
Application US20260096959A1 Kind: A1 Apr 09, 2026
Assignee
R.M CREIGHTON DENTAL PTY LTD
Inventors
Graham G. Craig
Abstract
A method of treating a carious lesion in a tooth which includes a step of applying a first dental solution to the carious lesion of the tooth, applying a second dental solution to the treated carious lesion within less than 10 minutes of the step of applying the first dental solution. The treated carious lesion consolidates forming a crust having a matte black surface and comprising nanoparticles after about 3-5 weeks. The first dental solution comprises an organic or inorganic silver salt and the second dental solution comprises an organic or inorganic reducing agent.
CPC Classifications
A61K 8/19 A61K 8/345 A61Q 11/00 A61K 2800/413 A61K 2800/92
Filing Date
2025-09-30
Application No.
19345469
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.